The Impact of Genexpert MTB/RIF Technology on the Minimization of Tuberculosis: A Review of Literature
Felix Kodzo Besah Sorvor, Ebenezer Ato Ewusie
Asian Journal of Medicine and Health · pp. 1–12 · Published 5 Jan 2024
10.9734/ajmah/2024/v22i1969Abstract
The molecular revolution in tuberculosis (TB) diagnosis has ushered in a new era of patient treatment that is quicker, more accurate, and clinically appropriate. In cases where treatment resistance is suspected or if tuberculosis (TB) is present, the most cutting-edge molecular diagnostic tool available is the Xpert test developed by Cepheid in Sunnyvale, California. In December 2010, it was swiftly recognized as the main technique for TB diagnosis by the World Health Organization. This comprehensive review provides an in-depth understanding of TB and GeneXpert technology and its impact on the minimization of TB. The leading infectious disease killer in 2019 was tuberculosis (TB). Worldwide, tuberculosis (TB) killed an estimated 1.2 million people in 2019, with an additional 208,000 lost to the disease among HIV-positive individuals. almost the world, the sickness affected almost 10.0 million people. Of all tuberculosis cases, 88% were in adults, while 12% were in children less than 15 years old. The 2019 tuberculosis case rates were lower in the East Mediterranean (8.2%), the Americas (2.9%), and Europe (2.5%), compared to the World Health Organization (WHO) zones of South-East Asia (44%), Africa (25%), and the Western Pacific (18%). This study will provide an in-depth understanding of GeneXpert technology and its impact on the healthcare system.
References (35)
- 1 Global tuberculosis report (2014)
- 2 Global Tuberculosis Report 2020 – Reflections on the Global TB burden, treatment and prevention efforts [DOI]
- 3 Risk Factors for Tuberculosis [DOI]
- 4 THE PROGNOSIS OF A POSITIVE TUBERCULIN REACTION IN CHILDHOOD AND ADOLESCENCE [DOI]
- 5 The Role of Medicine: Dream, Mirage, or Nemesis? [DOI]
- 6 Reasons for the decline of mortality in england and wales during the nineteenth century [DOI]
- 7 The White Plague: Tuberculosis, Man and Society [DOI]
- 8 Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults [DOI]
- 9 Detection of Drug-Resistant Tuberculosis by Xpert MTB/RIF in Swaziland [DOI]
- 10 Comparison of Xpert MTB/RIF with Line Probe Assay for Detection of Rifampin-Monoresistant Mycobacterium tuberculosis [DOI]
- 11 Yield of HIV-associated tuberculosis during intensified case finding in resource-limited settings: a systematic review and meta-analysis [DOI]
- 12 Diagnostic performance of GeneXpert MTB/RIF in detecting MTB in smear-negative presumptive TB patients [DOI]
- 13 Public health nihilism vs pragmatism: history, politics, and the control of tuberculosis. [DOI]
- 14 Impact of Xpert MTB/RIF Testing on Tuberculosis Management and Outcomes in Hospitalized Patients in Uganda [DOI]
- 15 Challenges in Implementing HIV Load Testing in South Africa [DOI]
- 16 Health systems performance in managing tuberculosis: analysis of tuberculosis care cascades among high-burden and non-high-burden countries [DOI]
- 17 Multicenter Feasibility Study To Assess External Quality Assessment Panels for Xpert MTB/RIF Assay in South Africa [DOI]
- 18 Uniting to end the TB epidemic: advances in disease control from prevention to better diagnosis and treatment [DOI]
- 19 Reasons for the Decline of Mortality in England and Wales during the Nineteenth Century [DOI]
- 20 4 THE IMPORTANCE OF SOCIAL INTERVENTION IN BRITAIN’S MORTALITY DECLINE c.1850–1914* A Reinterpretation of the Role of Public Health1 [DOI]
- 21 Dried Culture Spots for Xpert MTB/RIF External Quality Assessment: Results of a Phase 1 Pilot Study in South Africa [DOI]
- 22 Xpert MTB/RIF: a game changer for the diagnosis of pulmonary tuberculosis in children? [DOI]
- 23 Bacillus Calmette–Guerin [DOI]
- 24 The Modern Epidemic: A History of Tuberculosis in Japan [DOI]
- 25 Impact of the GeneXpert MTB/RIF Technology on Tuberculosis Control [DOI]
- 26 Bargaining for Life: A Social History of Tuberculosis, 1876-1938. [DOI]
- 27 Molecular epidemiology and drug susceptibility profiles of Mycobacterium tuberculosis complex isolates from Northern Ghana [DOI]
- 28 An Interpretation of the Modern Rise of Population in Europe [DOI]
- 29 Medication Compliance for Tuberculosis Patients with Quote TB Light at Public Health Center in 2020 [DOI]
- 30 CLINICAL TUBERCULOSIS [DOI]
- 31 Re‐emergent yellow fever: new faces of an old killer [DOI]
- 32 Tuberculosis epidemiology [DOI]
- 33 Data for action: collection and use of local data to end tuberculosis [DOI]
- 34 Commentary: Punishment and Palmer [DOI]
- 35 10.20527/jbk.v7i1 [DOI]
Cited by 12
Xiaodong Hu, Jian Huang, Shu-Hang Dong · Journal of Controlled Release · 2026
David Christianto, N. Mertaniasih, A. Permatasari · Journal of Pure and Applied Microbiology · 2025
Tianzhi Le, Fanfeng Shi, Meng Ge · EAI Endorsed Transactions on Pervasive Health and Technology · 2024
Kwame Kumi Asare, D. E. Azumah, Czarina Owusua Adu-Gyamfi · BMC Infectious Diseases · 2024
Xike Zhou, Yan Peng, Mohan Huang · Diagnostic Microbiology and Infectious Disease · 2025
Reza Faryabi, Ali Kamali, Rasoul Raesi · Current Respiratory Medicine Reviews · 2025
Showing 6 of 12 known citations — external sources report more than can currently be individually listed.
Related research
- Maternal Age and Congenital Anomalies among Newborns in a Tertiary Health Facility in Benue State, North Central Nigeria — shares topic coverage
- Early Diagnosis of Neonatal Sepsis: A Review of the Current Methods in Clinical Practice — shares topic coverage
- Skeletal Dysplasia: Approach to Simplify Diagnosis, Looking for Radiographic Clue Signs — shares topic coverage
- Impact of Radiology on the Early Identification of Waterhouse-friderichsen Syndrome: A Case Study — shares topic coverage
- Harnessing Artificial Intelligence in Healthcare Analytics: From Diagnosis to Treatment Optimization — shares topic coverage
Article metrics
Real usage data collected on this platform.
69
Page views
0
PDF downloads
31
Outbound clicks
12
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.